The effect of regulatory T-cell depletion on the spectrum of organ-specific autoimmune diseases in nonobese diabetic mice at different ages

Autoimmunity

Volumn 44, Issue 6, 2011, Pages 504-510

  Nakahara, Mami ^a   Nagayama, Yuji ^a   Ichikawa, Tatsuki ^b   Yu, Liping ^c   Eisenbarth, George S ^c   Abiru, Norio ^b  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

NOD mice; Regulatory T cells; Sialitis; Thyroiditis; Type 1 diabetes

Indexed keywords

AUTOANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; INSULITIS; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS; REGULATORY T LYMPHOCYTE; SALIVARY GLAND; SIALITIS; T CELL DEPLETION; THYROID GLAND; THYROIDITIS;

AGING; ANIMALS; ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; FEMALE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED NOD; SIALADENITIS; T-LYMPHOCYTES, REGULATORY; THYROIDITIS;

EID: 80051497493     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2010.548839     Document Type: Article

References (31)

1. Anderson MS, Bluestone JA. The NOD mouse: A model of immune dysregulation. Annu Rev Immunol 2005;23: 447-485. (Pubitemid 40563177)
2. Bach JF, Chatenoud L. Tolerance to islet autoantigens in type 1 diabetes. Annu Rev Immunol 2001;19:131-161. (Pubitemid 32368032)
3. \+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004;22:531-562. (Pubitemid 38680433)
4. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-1061. (Pubitemid 36222930)
5. Apostolou I, von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J Exp Med 2004;199: 1401-1408. (Pubitemid 38685731)
6. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzwei MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005;6:1219-1227. (Pubitemid 43045633)
7. Haribhai D, Lin W, Edwards B, Ziegelbauer J, Salzman NH, Carlson MR, Li SH, Simpson PM, Chatila TA, Williams CBA. central role for induced regulatory T cells in tolerance induction in experimental colitis. J Immunol 2009;182: 3461-3468.
8. \+ regulatory T cells by peripheral expansion. J Immunol 2004;173:7259-7268. (Pubitemid 39628162)
9. \+ regulatory T cells by TGF-b induction of transcription factor Foxp3. J Exp Med 2003;198:1875-1886. (Pubitemid 38032120)
10. \+ regulatory T cells and for expansion of these cells. J Immunol 2007;178:2018-2027. (Pubitemid 46233398)
11. \+) T cells promotes diabetes. J Leukoc Biol 2008;84:431-439.
12. \+ T cell levels in NOD mice. Proc Natl Acad Sci USA 2002;99:12287-12292.
13. Berzins SP, Venanzi ES, Benoist C, Mathis D. T-cell compartments of prediabetic NOD mice. Diabetes 2003;52: 327-334. (Pubitemid 36173186)
14. Mellanby RJ, Thomas D, Phillips JM, Cooke A. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4\+ CD25\+ Foxp3\+ regulatory T cells. Immunology 2007;121:15-28. (Pubitemid 46537670)
15. \+ regulatory T cells during auto¬immune diabetes. J Exp Med 2005;201:1333-1346. (Pubitemid 40629075)
16. Gregori S, Nadia G, Simona S, Luciano A. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol 2003;171:4040-4047. (Pubitemid 37238678)
17. D'Alise AM, Auyeung V, Feuerer M, Nishio J, Fontenot J, Benoist C, Mathis D. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc Natl Acad Sci USA 2008;105:19857-19862.
18. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegle SF, Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001;27:68-73. (Pubitemid 32044521)
19. Schorle H, Holtschke T, Hünig T, Schimpl A, Horak I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991;352: 621-624. (Pubitemid 21912393)
20. \+ immunoregulatory T cells that control autoimmune diabetes. Proc Natl Acad Sci USA 2000;12:431-440.
21. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various auto¬immune diseases. J Immunol 1995;155:1151-1164.
22. \+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 2005;201:723-735. (Pubitemid 40395118)
23. Chen Z, Benoist C, Mathis D. How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc Natl Acad Sci USA 2005;102:14735-14740. (Pubitemid 41457125)
24. Fukushima K, Kobayashi M, Nagayama Y, Satoh T, Nakahara M, Kawasaki E, Yamasaki H, Ueha S, Matsushima K, Liu E, Eisenbarth GS, Eguchi K, Abiru N. Combined activation of innate and adaptive immunity with polyinosinic- polycytidylic acid and insulin B:9-23 self-peptide in the genetically susceptible NOD mouse: Differential effects on insulitis and diabetes progression. Biochem Biophys Res Commun 2008;367:719-724.
25. Kobayashi M, Abiru N, Arakawa T, Fukushima K, Zhou H, Kawasaki E, Yamasaki H, Liu E, Miao D, Wong FS, Eisenbarth GS, Eguchi K. Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, sup¬presses the expression of insulin autoantibodies and prevents diabetes. J Immunol 2007;179:2082-2088.
26. h4 mice from developing auto¬immune thyroiditis. Endocrinology 2009;150:1545-1551.
27. Ansari MA, Dhar M, Spieker S, Bakht N, Rahman AM, Moore WV, Jacobson JD. Modulation of diabetes with gonadotropin-releasing hormone antagonists in the nonobese mouse model of autoimmune diabetes. Endocrinology 2004; 145:337-342. (Pubitemid 38094528)
28. Bach JF. Insulin-dependent diabetes mellitus as an auto¬immune disease. Endor Rev 1994;15:516-535.
29. \+ Regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol 2002;168:5979-5983. (Pubitemid 34620008)
30. \+ T cells controlling distinct organ-specific autoimmune diseases. Proc Natl Acad Sci USA 2003;100: 15806-15811. (Pubitemid 38021071)
31. Abiru N, Yu L, Miao D, Maniatis AK, Liu E, Moriyama H, Eisenbarth GS. Transient insulin autoantibody expression independent of development of diabetes: Comparison of NOD and NOR strains. J Autoimmun 2001;17:1-6. (Pubitemid 32751876)